Short cervix syndrome: current knowledge from etiology to the control
- First Online:
- 841 Downloads
Preterm delivery is one of the most serious public health problems and is the most important factor relating to neonatal morbidity and mortality. The strategies for preventing it include understanding the risk factors, with specific interventions. Recently, uterine cervix measurements using ultrasonography and vaginal administration of progesterone have gained importance in predicting and secondarily preventing spontaneous preterm delivery.
To describe the short cervix syndrome, including its etiology, diagnosis, and possible therapies.
Research in ISI, Pubmed, and Scielo database using the words short cervix, preterm delivery, sludge, cervical funneling, cervical gland area, progesterone, cerclage, and pessary.
We found a lot of articles about this topic, including randomized controlled trials. The etiology is multifactorial, being the diagnosis based in a cervix shortening at 20–24 weeks. The history and measurement of cervix length by transvaginal ultrasound have been shown to be effective to select the high risk pregnancies. The progesterone, cervical cerclage, and cervical pessary showed to be effective to reduce the preterm delivery in pregnant women with short cervix.
The successful management of pregnant women presenting a short cervix depends on the understanding that cervical shortening is the final common path for several causes of preterm delivery. The best approach should be individualized to each patient.
KeywordsShort cervix Preterm delivery Transvaginal ultrasound Progesterone Cervical cerclage Cervical pessary
- 7.Mancuso MS, Szychowski JM, Owen J, Hankins G, Iams JD, Sheffield JS et al. (2010) Cervical funneling: effect on gestational length and ultrasound-indicated cerclage in high-risk women. Am J Obstet Gynecol 203:259.e1–259.e5Google Scholar
- 12.Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group (2007) Progesterone and the risk of preterm among women with a short cervix. N Engl J Med 357:462–469Google Scholar
- 16.Keeler SM, Kiefer DG, Rust OA, Vintzileos A, Atlas RO, Bornstein E et al. (2009) Comprehensive amniotic fluid cytokine profile evaluation in women with a short cervix: which cytokine(s) correlates best with outcome? Am J Obstet Gynecol 201:276.e1–276.e6Google Scholar
- 17.Kiefer DG, Keeler SM, Rust O, Chow SS, Craig ME, Peltier MR et al. (2012) Amniotic fluid inflammatory score is associated with pregnancy outcome in patients with mid trimester short cervix. Am J Obstet Gynecol 206:68.e1–68.e6Google Scholar
- 19.Yoneda S, Sakai M, Sasaki Y, Shiozaki A, Hidaka T, Saito S (2007) Interleukin-8 and glucose in amniotic fluid, fetal fibronectin in vaginal secretions and preterm labor index based on clinical variables are optimal markers for preterm delivery in patients with intact membranes. J Obstet Gynaecol Res 33:38–44PubMedCrossRefGoogle Scholar
- 22.Andersen HF, Nugent CE, Wanty SD, Hayashi RH (1990) Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length. Am J Obstetr Gynecol 163:859–867Google Scholar
- 23.Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M et al (2011) Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 38:18–31PubMedCrossRefGoogle Scholar
- 25.O’Brien JM, Defranco EA, Adair CD, Lewis DF, Hall DR, How H et al (2009) Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 34:653–659PubMedCrossRefGoogle Scholar
- 36.van Os MA, van der Ven JA, Kleinrouweler CE, Pajkrt E, de Miranda E, van Wassenaer A et al (2011) Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study. BMC Pregnancy Childbirth 11:77PubMedCrossRefGoogle Scholar
- 37.Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O’Brien JM, Cetingoz E et al. (2012) Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 206:124.e1–124.e19Google Scholar
- 47.Fox NS, Saltzman DH, Klauser CK, Peress D, Gutierrez CV, Rebarber A (2009) Prediction of spontaneous preterm birth in asymptomatic twin pregnancies with the use of combined fetal fibronectin and cervical length. Am J Obstet Gynecol 201:313.e1–313.e5Google Scholar
- 48.Klein K, Rode L, Nicolaides KH, Krampl-Bettelheim E, Tabor A; PREDICT Group (2011) Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis. Ultrasound Obstet Gynecol 38:281–287Google Scholar
- 50.Rode L, Klein K, Nicolaides KH, Krampl-Bettelheim, Tabor A, for the PREDICT Group (2011) Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol 38:272–280Google Scholar